EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Phosphaturia Exacerbates Tubular Injury and Cyst Formation in Polycystic Kidney Disease

Kyle P Jansson iD, Jordan Kuluva, Taylor Swanson, Shiqin Zhang, Timothy A Fields, Katherine I Swenson-Fields, Darren P Wallace iD, Peter S Rowe, Jason R Stubbs iD

Kidney360 · 2026-07 · 7 (7) · 1475-1488

DOI: 10.34067/kid.0000001149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney360, online erschienen am 23.04.2026. Verfasst von Kyle P Jansson und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, Kansas. Hauptthemen laut MEDLINE: Kidney Tubules, Polycystic Kidney Diseases, Phosphates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NCI NIH HHS, Kansas Intellectual and Developmental Disabilities Research Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points High concentrations of tubular phosphate directly contribute to kidney mineral retention, tubular injury/inflammation, and cyst growth in mice. Human polycystic kidney disease kidneys exhibit subclinical calcium-phosphate microcrystals that may be promoting kidney pathology in this setting. Phosphaturia and kidney mineral deposition may be novel and modifiable therapeutic targets to slow polycystic kidney disease progression.

Background

Accumulating evidence supports a direct contribution of abnormalities in phosphate homeostasis to progression of polycystic kidney disease (PKD); however, the mechanisms for these relationships remain undefined. A universal feature of nephron loss in all forms of kidney disease is increased urinary phosphate excretion by residual functional nephrons that helps to maintain systemic phosphate balance. To date, no studies have examined the direct contribution of urinary phosphate to kidney pathology in PKD.

Methods

We first examined the impact of dietary phosphate on kidney outcomes in Pkd1 RC/RC mice, an orthologous murine model of PKD. Next, to more specifically delineate the direct contribution of urinary phosphate to kidney pathology, we characterized kidney phenotypes in phosphaturic Slc34a1 −/− mice. We then investigated how increasing urinary phosphate excretion through Slc34a1 deletion affected cystic kidney disease progression in Pkd1 RC/RC mice. Finally, to define the relevance of our findings to human PKD, we conducted high-resolution imaging and trace mineral analysis of human PKD and control kidney specimens to assess the prevalence and composition of subclinical mineral deposition.

Results

Pkd1 RC/RC mice fed a high phosphate diet exhibited kidney injury with activation of early fibrosis pathways, accelerated cyst growth, and phosphate-based crystal deposition that spatially colocalized with macrophages. Slc34a1 −/− mice demonstrated extensive nephrocalcinosis, tubular microcyst formation, and evidence of early kidney injury, inflammation, and fibrosis. Moreover, compound mutant Pkd1 RC/RC , Slc34a1 −/− mice had increased kidney cyst burden accompanied by reduced kidney function compared with Pkd1 RC/RC , Slc34a1 +/+ controls. Finally, micro-computed tomography and trace mineral analyses of human kidneys revealed consistent deposition of calcium-phosphate microcrystals in PKD kidneys.

Conclusions

Increased urinary phosphate excretion directly contributes to kidney injury, cyst formation/growth, inflammation, and fibrosis. Urinary phosphate excretion and tubular mineral solubility may represent novel therapeutic targets for slowing PKD progression in humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TubulesPolycystic Kidney DiseasesPhosphatesAnimalsMiceDisease Models, AnimalDisease ProgressionHumansMice, KnockoutMaleCystsSodium-Phosphate Cotransporter Proteins, Type IIa

Stichwörter der Autor:innen

ADPKDCKDhyperphosphatemiamacrophagesmineral metabolismpathophysiology

Substanzen

PhosphatesSlc34a1 protein, mouseSodium-Phosphate Cotransporter Proteins, Type IIa

Autor:innen und Institutionen

  • The Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, Kansas.
  • Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas.
  • Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas.
  • Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, Kansas.

ORCID-Profile: Kyle P Jansson, Darren P Wallace, Jason R Stubbs

Förderung

  • NIH HHS
  • NCI NIH HHS
  • Kansas Intellectual and Developmental Disabilities Research Center
  • NIDDK NIH HHS
  • NICHD NIH HHS
  • NIGMS NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Cancer Institute

Zitieren

APA

Jansson, K. P., Kuluva, J., Swanson, T., Zhang, S., Fields, T. A., Swenson-Fields, K. I., Wallace, D. P., Rowe, P. S., & Stubbs, J. R. (2026). Phosphaturia Exacerbates Tubular Injury and Cyst Formation in Polycystic Kidney Disease. Kidney360, 7(7), 1475-1488. https://doi.org/10.34067/kid.0000001149

Vancouver

Jansson KP, Kuluva J, Swanson T, Zhang S, Fields TA, Swenson-Fields KI, et al. Phosphaturia Exacerbates Tubular Injury and Cyst Formation in Polycystic Kidney Disease. Kidney360. 2026;7(7):1475-1488. doi:10.34067/kid.0000001149

BibTeX
@article{Jansson2026,
  author = {Jansson, Kyle P and Kuluva, Jordan and Swanson, Taylor and Zhang, Shiqin and Fields, Timothy A and Swenson-Fields, Katherine I and Wallace, Darren P and Rowe, Peter S and Stubbs, Jason R},
  title = {Phosphaturia Exacerbates Tubular Injury and Cyst Formation in Polycystic Kidney Disease},
  journal = {Kidney360},
  year = {2026},
  volume = {7},
  number = {7},
  pages = {1475--1488},
  doi = {10.34067/kid.0000001149}
}
Kostenlos starten →